Targeting DNA Methylation and B7-H3 in RB1-Deficient and Neuroendocrine Prostate Cancer

Researchers identified that deletion of DNA methyltransferases genes decreased expression of neuroendocrine lineage markers and substantially reduced neuroendocrine prostate cancer tumor development and metastasis in vivo.